نتایج جستجو برای: posaconazole

تعداد نتایج: 1355  

Journal: :Journal of medicinal chemistry 2006
Gustavo Benaim John M Sanders Yael Garcia-Marchán Claudia Colina Renee Lira Aura R Caldera Gilberto Payares Cristina Sanoja Juan Miguel Burgos Annette Leon-Rossell Juan Luis Concepcion Alejandro G Schijman Mariano Levin Eric Oldfield Julio A Urbina

There is no effective treatment for the prevalent chronic form of Chagas' disease in Latin America. Its causative agent, the protozoan parasite Trypanosoma cruzi, has an essential requirement for ergosterol, and ergosterol biosynthesis inhibitors, such as the antifungal drug posaconazole, have potent trypanocidal activity. The antiarrhythmic compound amiodarone, frequently prescribed for the sy...

Journal: :The Journal of antimicrobial chemotherapy 2014
Petros Pechlivanoglou Hoa H Le Simon Daenen John A Snowden Maarten J Postma

OBJECTIVES Patients receiving therapy for haematological malignancies have a higher risk of invasive fungal infections (IFIs). Antifungal prophylaxis is an effective strategy against IFIs, but relative effectiveness estimates across agents are inconclusive. A mixed treatment comparison (MTC) was conducted to estimate the relative effectiveness of all agents for a number of outcomes of interest....

2015
Ali Zarei Mahmoudabadi Ali Rezaei-Matehkolaei Fataemeh Ghanavati

BACKGROUND Candiduria is a rising condition among hospitalized patients and Candida albicans is the most common recovered agent. However, non-albicans Candida species (NACs) such as C. glabrata, C. krusei, C. parapsilosis, and C. tropicalis are also important. Although most Candida species especially C. albicans are sensitive to routinely used antifungals, an increasing trend in resistance has ...

Journal: :Antimicrobial agents and chemotherapy 2016
Hongfei Zhang M Hong Nguyen Cornelius J Clancy Rujuta Joshi Wenchen Zhao Chris Ensor Raman Venkataramanan Ryan K Shields

Invasive fungal infections (IFIs) are common among lung transplant recipients (LTRs). Posaconazole is an important antifungal agent for both prophylaxis and treatment of IFIs; however, detailed pharmacokinetic data are limited among LTRs, particularly those with cystic fibrosis (CF). Our objective was to conduct a pharmacokinetic study of posaconazole oral suspension among LTRs, with particular...

Journal: :The Journal of antimicrobial chemotherapy 2005
Punnee Pitisuttithum Ricardo Negroni John R Graybill Beatriz Bustamante Peter Pappas Stanley Chapman Roberta S Hare Catherine J Hardalo

OBJECTIVES A multinational, multicentre, open-label clinical trial was conducted to evaluate the safety and efficacy of posaconazole, an extended-spectrum triazole antifungal agent, in subjects with invasive fungal infections who had refractory disease or who were intolerant of standard antifungal therapy. In this subanalysis, we report on those subjects in this trial who had a fungal infection...

Journal: :The Journal of antimicrobial chemotherapy 2012
Maria Drogari-Apiranthitou Foteini-Despina Mantopoulou Anna Skiada Lambrini Kanioura Maria Grammatikou Georgia Vrioni Aggeliki Mitroussia-Ziouva Athanassios Tsakris George Petrikkos

OBJECTIVES Mucormycetes (formerly known as zygomycetes of the order Mucorales) and hyaline moulds such as those of the genus Fusarium or Paecilomyces are emerging as significant human pathogens. The aim of the study was to determine the in vitro antifungal susceptibility of these fungi to older and newer antifungals and to investigate the antifungal activity of amphotericin B, posaconazole and ...

Journal: :Journal of medicine 2021

With increasing incidence of Severe Acute Respiratory Distress Virus 2(SARS -CoV -2) in India, there has been growing reports super infections post covid 19 period. Long COVID refers to persistence COVID19 symptoms for weeks months. While most common manifestation long is fatigue and ill health, it may lead development life-threatening complications like Pulmonary Mucormycosis. We report a case...

Journal: :The Kaohsiung Journal of Medical Sciences 2020

Journal: :Antimicrobial Agents and Chemotherapy 2018

2010
Hans-Jürgen Tietz

Therapy of chronic recurrent vulvovaginal candidiasis (VVC) caused by Candida glabrata is still rare in comparison to C. albicans infection, but therapy remains more difficult. Combination therapy with topical antifungals may improve therapy outcome, but still standard agents as fluconazole or itraconazole often fail. Posaconazole is a new systemic triazole with a wide antifungal spectrum inclu...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید